Companies Dominating the Bioresorbable Collagen Implant Landscape
- Allergan, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Zimmer Biomet Holdings, Inc.
- Galderma S.A.
- CollPlant Holdings Ltd.
- Collagen Matrix, Inc.
- Merz Pharma GmbH & Co. KGaA
- RegenLab SA
- Croma-Pharma GmbH
- Dr. Suwelack AG & Co. KG
- Mentor Worldwide LLC
Browse Key Market Insights with Data Illustration:
In the News
- Zimmer Biomet acquired Embody, Inc., a privately-held medical device company focused on soft tissue healing, for USD 155 million at closing and up to an additional USD 120 million subject to achieving future regulatory and commercial milestones over three years. The acquisition was aimed at expanding Zimmer Biomet's portfolio of soft tissue healing products and solutions.
- Zimmer Biomet merged with Biomet, Inc., to form a global leader in musculoskeletal healthcare. The merger combined Zimmer's and Biomet's portfolios of products and solutions, including joint reconstruction, sports medicine, and spine care.
